Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 3,572 | 2,855 | 3,072 | 2,651 | 3,200 |
| Operating Income | -3,572 | -2,855 | -3,072 | -2,651 | -3,200 |
| Other Income | -19 | -3 | -33 | -8 | 1 |
| Pre-tax Income | -3,591 | -2,858 | -3,105 | -2,658 | -3,199 |
| Net Income Continuous | -3,591 | -2,858 | -3,105 | -2,658 | -3,199 |
| Net Income | $-3,591 | $-2,858 | $-3,105 | $-2,658 | $-3,199 |
| EPS Basic Total Ops | -2,045.45 | -2,325.18 | -2,709.79 | -2,097.90 | -2,797.20 |
| EPS Basic Continuous Ops | -2,037.02 | -2,320.88 | -2,594.67 | -2,217.58 | -2,683.96 |
| EPS Diluted Total Ops | -2,045.45 | -2,325.18 | -2,709.79 | -2,097.90 | -2,797.20 |
| EPS Diluted Continuous Ops | -2,037.02 | -2,320.88 | -2,594.67 | -2,217.58 | -2,683.96 |
| EBITDA(a) | $-3,516 | $-2,803 | $-3,018 | $-2,589 | $-3,140 |